• No results found

Allogeneic haematopoietic stem cell donation and transplantation across the MHC class I barrier: "Faster is better than more. More is better than less".

N/A
N/A
Protected

Academic year: 2021

Share "Allogeneic haematopoietic stem cell donation and transplantation across the MHC class I barrier: "Faster is better than more. More is better than less"."

Copied!
21
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Citation

Heemskerk, M. B. A. (2006, September 28). Allogeneic haematopoietic stem cell donation and transplantation across the MHC class I barrier: "Faster is better than more. More is better than less". Retrieved from https://hdl.handle.net/1887/4578

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in theInstitutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/4578

(2)

6

Allogeneic MHC class I molecules with numerous

sequence differences do not elicit a CTL response.

0DUWLQ%$+HHPVNHUN'DYH/5RHOHQ0DUOLHV.$'DQNHUV

-RQ-YDQ5RRG)UDQV+-&ODDV1,OLDV,1'R[LDGLV0DFKWHOG2XGVKRRUQ

(3)
(4)

Abstract

(5)

Introduction

(6)

RUVHOHFWLRQDQGFRQIRUPDWLRQRISHSWLGHVSUHVHQWHGE\0+&7KHPRWLIVLQYROYHGLQ0+& 7&5 DVVRFLDWLRQ DUH SUHGRPLQDQWO\ ORFDWHG LQ WKH _ helices of the _1 and _ GRPDLQ12

7KHPRWLIVLQYROYHGLQSHSWLGHVHOHFWLRQDQGFRQIRUPDWLRQDUHORFDWHGZLWKLQWKHSHSWLGH binding groove in the `VKHHWDQGVRPHLQWKH_KHOLFHV$TXDQWLWDWLYHDQGRUTXDOLWDWLYH

GLVWLQFWLRQ FDQ EH PDGH EHWZHHQ 0+& GLIIHUHQFHV 0+& KDV PDQ\ SRO\PRUSKLF DPLQR DFLGSRVLWLRQV6RPH0+&PROHFXOHVGLIIHUE\RQO\DIHZDPLQRDFLGVZKLOHRWKHUVKDYH PDQ\GLIIHUHQFHV&HUWDLQPRWLIVKRZHYHUPD\EHPRUHLPSRUWDQWIRUSHSWLGHVHOHFWLRQ SHSWLGH FRQIRUPDWLRQ RU7&5 FRQWDFWV WKDQ RWKHUV )XUWKHUPRUH VRPH DPLQR DFLGV KDYH IXQFWLRQDOVLPLODULWLHVZKLOHRWKHUDPLQRDFLGVKDYHYHU\GLVWLQFWSURSHUWLHV

7KHTXHVWLRQLVZKHWKHU7FHOODOORUHDFWLYLW\FDQEHSUHGLFWHGE\WKHDPLQRDFLGVHTXHQFH of the _1 and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

Materials and Methods

Donor/recipient pairs. 7KLVDQDO\VLVFRQFHUQHGGRQRUSDWLHQWSDLUVUHJLVWHUHGE\WKH(XURSGRQRUIRXQGDWLRQIURP WR7KHSDWLHQWVZHUHIURP'XWFKKDHPDWRSRLHWLFVWHPFHOOWUDQVSODQWDWLRQ FHQWHUV7KHGRQRUVRULJLQDWHGIURPWKHQDWLRQDOGRQRUUHJLVWU\RIWKH(XURSGRQRUIRXQGDWLRQ ,QWHUQDWLRQDOGRQRUUHJLVWULHVDQGUHODWHGGRQRUV$OOSDLUVKDGDVLQJOH+/$$%RU& DQWLJHQDOOHOHPLVPDWFKLQWKHJUDIWYHUVXVKRVWGLUHFWLRQDUHPLVPDWFKHGIRU+/$$ DQWLJHQPLVPDWFKHVDOOHOHPLVPDWFKHV IRU+/$% DQWLJHQPLVPDWFKDOOHOH PLVPDWFKHV DQGIRU+/$& DQWLJHQPLVPDWFKHVDOOHOHPLVPDWFKHV 7KHVSHFL¿F +/$ DOOHOH PLVPDWFKHV RI DOO GRQRUUHFLSLHQW FRPELQDWLRQV WHVWHG DUH VKRZQ LQ7DEOH  $OOSDLUVDUHFRPSDWLEOHIRUWKH+/$'5%DQG'4%DOOHOHV:HGLGQRWH[FOXGHWKH SDLUVZKLFKZHUH+/$'3%PLVPDWFKHGDVWKHSRZHURIWKHDQDO\VLVZRXOGEHFRPHWRR ORZ

(7)

HLA-Cw*0303/HLA-Cw*0304 mismatched pairs.

$OO&7/SDVVD\VSHUIRUPHGIRUGRQRUSDWLHQWSDLUVZLWKDQ+/$&Z +/$&Z  PLVPDWFK Q   FRQWDLQLQJ RQH DPLQR DFLG VXEVWLWXWLRQ RQ SRVLWLRQ  UHVXOWHG LQ DQ XQGHWHFWDEOH &7/S IUHTXHQF\ 3RVLWLRQ  OLHV RXWVLGH WKH _ KHOLFHV ` VKHHW DQG RWKHU NQRZQIXQFWLRQDOJURXSVRIWKHPROHFXOHDQGLVWKXVQRWUHOHYDQWIRU7FHOOUHFRJQLWLRQ3

7KLVPLVPDWFKLVWKHUHIRUHGLVWLQFWLYHO\GLIIHUHQWIURPWKHRWKHU+/$&PLVPDWFKHVWKDW KDYHVXEVWLWXWLRQVRQIXQFWLRQDOSDUWVRIWKHPROHFXOH7KHVHSDLUVZHUHWKHUHIRUHH[FOXGHG IURPWKHDQDO\VLV

HLA genotyping and amino acid sequencing.

$OOGRQRUVDQGSDWLHQWVZHUHW\SHGDWKLJKUHVROXWLRQIRU+/$$%&'5%'4%DQG '3%DVGHVFULEHGEHIRUH 37KHIROORZLQJWHFKQLTXHVZHUHXVHGSRO\PHUDVHFKDLQUHDFWLRQ

VHTXHQFHVSHFL¿FSULPHUIRUKLJKUHVROXWLRQDOOHOHW\SLQJDQGVHTXHQFHEDVHGW\SLQJIRU DSDUWRIWKH+/$&DOOHOHV7KHDPLQRDFLGVHTXHQFHVZHUHREWDLQHGIURPWKHZHEVLWHRI WKH (XURSHDQ %LRLQIRUPDWLFV ,QVWLWXWH 7KH PLVPDWFKHG +/$ PROHFXOHV ZHUH H[DPLQHG

IRUDPLQRDFLGGLIIHUHQFHV VXEVWLWXWLRQV RQWKH_1 and _GRPDLQ SRVLWLRQV 7KH _KHOLFHVRI+/$$%DQG&FRQVLVWRISRVLWLRQVDQGDQGWKH` sheet of +/$$%DQG&LVGHWHUPLQHGE\SRVLWLRQVDQG 

Cytotoxic T-Lymphocyte precursor assay.

7KH&7/SDVVD\VZHUHSHUIRUPHGIRUWKHVHOHFWLRQRIWKHEHVWDOORJHQHLFKDHPDWRSRLHWLF VWHP FHOO GRQRU IRU WKH SDWLHQWV7KH &7/S DVVD\ ZDV SHUIRUPHG DV GHVFULEHG E\ =KDQJ et al ZLWK PLQRU PRGL¿FDWLRQV DV GHVFULEHG E\ 2XGVKRRUQ et al37KH WDUJHW FHOOV ZHUH

ODEHOHGZLWK&U7KHUHSURGXFLELOLW\RIWKLVDVVD\KDVEHHQGHVFULEHGSUHYLRXVO\In each

DVVD\GRQRUFHOOVZHUHXVHGDVWKHUHVSRQGHUDQGWKHSDWLHQWFHOOVDVWKHVWLPXODWRUDQGWDUJHW JUDIWYHUVXVKRVWGLUHFWLRQ ,QWKLVVWXG\DQXQGHWHFWDEOH&7/SIUHTXHQF\ZDVGH¿QHGDV &7/S”SHU3%/ DQGDGHWHFWDEOH&7/SIUHTXHQF\ZDVGH¿QHGDV&7/S!SHU 3%/:HWKXVVHOHFWHGDOOSDLUVZLWK&7/S”SHU3%/DQG&7/S!SHUPBL in RUGHUWRJHWWZRGLVWLQFWJURXSV7ZHQW\HLJKWSDLUVZLWKD&7/SIUHTXHQF\EHWZHHQWZRSHU 3%/DQG¿YHSHU3%/KDYHEHHQH[FOXGHGRXWRIWKHSDLUVDUHPLVPDWFKHGIRU +/$$IRU+/$%DQGIRU+/$&

Cytotoxic T-Lymphocyte precursor assay and natural killer cells.

%HVLGHVF\WRWR[LF7FHOOVQDWXUDONLOOHU 1. FHOOVDUHWKRXJKWWREHSRVVLEO\LQYROYHGLQ NLOOLQJRIWKHKRVWFHOOVLQWKH&7/SDVVD\1.FHOOUHDFWLYLW\FDQEHLQKLELWHGE\VSHFL¿F LQKLELWRU\ .,5 OLJDQGV17 +/$& PROHFXOHV EHDULQJ WKH 6HU DQG$VQ PRWLI &  DUH

(8)

$VQDQG/\VPRWLI & DUHOLJDQGVIRUWKHLQKLELWRU\.,5'/1.FHOOPHGLDWHG

DOORUHDFWLYLW\FDQRFFXUZKHQWKHWDUJHWFHOOVGRQRWKDYHWKHVDPHLQKLELWRU\PRWLIVDVWKH UHVSRQGHU

Statistical analysis.

7KH 0DQQ:KLWQH\ U WHVW ZDV XVHG WR GHWHUPLQH GLIIHUHQFHV LQ QXPEHU RI DPLQR DFLG VXEVWLWXWLRQV EHWZHHQ WKH SDLUV ZLWK DQ XQGHWHFWDEOH DQG GHWHFWDEOH &7/S IUHTXHQF\7R DQDO\]HWKHHIIHFWRILQWHUDFWLRQEHWZHHQYDULDEOHVRQ7FHOOUHDFWLYLW\WKHSURGXFWVRIWKH YDULDEOHVZHUHXVHG7KLVLQWHUDFWLRQWHUPLVEDVHGRQWKHLGHDWKDWLIERWKYDULDEOHVRIWKH SURGXFWDUHKLJKWKHSURGXFWLVKLJKHUWKDQZKHQRQO\RQHYDULDEOHLVKLJKHYHQZKHQWKH VXPRIYDULDEOHVLVWKHVDPH7KH&KL6TXDUHWHVWRULIPHQWLRQHGWKH)LVKHU¶VH[DFWWHVW ZDVXVHGWRFRPSDUHIUHTXHQFLHV

Results

(9)

Figure 1: Number of amino acid differences of single HLA class I incompatibilities versus T cell alloreactivity in vitro (CTLp/106 PBL). The

(10)

Amino acid substitutions in the _ helices and ` sheet of MHC class I.

7KHUHZDVDUHODWLRQEHWZHHQWKHQXPEHURIVXEVWLWXWLRQVLQWKH_ helices of HLA-C and &7/S IUHTXHQF\ )LJXUH   3DLUV ZLWK QR GHWHFWDEOH &7/S IUHTXHQF\ KDYH RQ DYHUDJH D KLJKHU QXPEHU RI LQFRPSDWLELOLWLHV LQ WKH _ KHOLFHV WKDQ WKRVH ZLWK D GHWHFWDEOH &7/S IUHTXHQF\ S  7KLVUHODWLRQZDVQRWIRXQGLQWKHJURXSRIGRQRUSDWLHQWSDLUVZLWKD VLQJOH+/$$RU±%GLIIHUHQFH1RUHODWLRQZDVIRXQGEHWZHHQWKHQXPEHURIVXEVWLWXWLRQV in the `VKHHWDQG&7/SIUHTXHQF\ )LJXUH 

+RZHYHUWKHUHVHHPVWREHDQLQWHUDFWLRQEHWZHHQWKHQXPEHURIDPLQRDFLGGLIIHUHQFHV in the _ helices and in the `VKHHWDQGWKHLUHIIHFWRQ7FHOODOORUHDFWLYLW\7KLVZDVPRUH DSSDUHQWIRU+/$&WKDQIRU+/$$DQG±%PLVPDWFKHGFRXSOHV$VVKRZQLQWKHXSSHU ULJKWTXDGUDQWRI)LJXUH+/$&GLIIHUHQFHVZLWK¿YHRUPRUHVXEVWLWXWLRQVLQWKH_ helices DQGDWOHDVW¿YHVXEVWLWXWLRQVLQWKH`VKHHWGLGQRWOHDGWRGHWHFWDEOH&7/SIUHTXHQFLHV +/$

Figure 2: Amino acid differences on positions 114 and 116 in the `sheet of MHC class I versus T cell alloreactivity in vitro (CTLp/106 PBL). The

(11)

Figure 3: Number of amino acid differences in the _ helices of MHC class I versus T cell alloreactivity in vitro (CTLp/106 PBL). 7KHQXPEHURISDLUVLQHDFKJURXSVLQJOH+/$$RU±%GLIIHUHQFHQ  &7/S”

 DQGQ  &7/S! VLQJOH+/$&GLIIHUHQFHQ  &7/S” DQGQ  &7/S! +RUL]RQWDO lines indicate the mean of each group. A statistical difference was found; HLA-C mismatched pairs with a undetectable CTLp frequency had on average a higher number of substitutions in the _ helices than the pairs with a detectable CTLp frequency (p = 0.03). No difference was found for HLA-A and -B differences (p = 0.67).

Figure 4: Number of amino acid differences in the ` sheet of MHC class I versus T cell alloreactivity in vitro (CTLp/106 PBL).7KHQXPEHURISDLUVLQHDFKJURXSVLQJOH+/$$RU±%GLIIHUHQFHQ  &7/S”

(12)

PLVPDWFKHVDUHVKRZQLQ7DEOH 7KHPHDQLQWHUDFWLRQWHUP DVGHVFULEHGLQ0HWKRGV ZDV KLJKHULQWKHJURXSRIWKHXQGHWHFWDEOH&7/SIUHTXHQFLHVFRPSDUHGWR S   'XHWRVPDOOQXPEHUVWKHGDWDRQ+/$$DQG%LVQRWFRQFOXVLYH S  ,QWKHXSSHU ULJKWTXDGUDQWRI)LJXUHWKHUHDUHWKUHHSDLUVZLWKQXPHURXVDPLQRDFLGGLIIHUHQFHVLQ the_ helices and in the `VKHHWWKDWGLGQRWOHDGWRGHWHFWDEOH&7/SIUHTXHQFLHV+RZHYHU WKHUHZHUHPDQ\SDLUVZLWKIHZDPLQRDFLGGLIIHUHQFHVWKDWGLGOHDGWRHLWKHUGHWHFWDEOHRU XQGHWHFWDEOH&7/SIUHTXHQFLHV 7KHUHVXOWVRQ+/$&GLIIHUHQFHVZHUHIXUWKHUVXEVWDQWLDWHGZLWKVHYHQDGGLWLRQDOO\VHOHFWHG SDLUV 7DEOH KDYLQJDVLQJOH+/$&GLIIHUHQFHWKDWGLIIHUVE\DWOHDVW¿YHDPLQRDFLGV in the `VKHHWDQGDWOHDVW¿YHLQWKH_KHOLFHVRQO\RQHRIWKHVHOHDGWRDGHWHFWDEOH&7/S IUHTXHQF\7KLVUHVXOWVLQDVLJQL¿FDQWDVVRFLDWLRQIRUWKHWRWDOJURXS S 7DEOH  7DEOH6SHFL¿F+/$PLVPDWFKHVRIDOOGRQRUUHFLSLHQWSDLUVVWXGLHGZLWKWKH&7/SDVVD\ +/$$PLVPDWFKHV Q     0101-2402   0201-0206 (n=2)  Q   0201-0205   0201-0301   0201-1101   0201-2402    Q   +/$%PLVPDWFKHV Q    Q   2702-2705    +/$&PLVPDWFKHV Q   Q   Q  A B 0102-0304 (n=2) B B 0102-0702 (n=2) B  0202-0303 (n=2) B B 0202-0701   Q  0202-0702 (n=2)  Q   0202-1402 B  Q   Q   Q  B  $GGLWLRQDOFRXSOHVZLWK+/$&PLVPDWFKHV Q  B B B  Q  B

A7KHVH SDLUV ZHUH H[FOXGHG IURP WKH DQDO\VLV DV GHVFULEHG LQ 0HWKRGV 7KHVHSDLUVZHUHH[FOXGHGIURPWKHDQDO\VLV DVGHVFULEHGLQ0HWKRGV 

(13)

Table 2: Observed frequency of T cell mediated alloreactivity in vitro related to the number amino acid differences in the _ helices and in the ` sheet of single HLA-C differences. &7/SIUHTXHQF\) 1 &7/SIUHTXHQF\! *URXSA  1 *URXSB   A*URXSFRQWDLQVWKHSDLUVZLWK¿YHRUPRUHDPLQRDFLGGLIIHUHQFHVLQWKH_ helices DQG¿YHRUPRUHLQWKH`VKHHWB*URXSLVWKHUHPDLQLQJJURXS*URXSKDVDQ LQVLJQL¿FDQWQXPEHURIFDVHVZLWKDGHWHFWDEOH&7/SIUHTXHQF\FRPSDUHGWRJURXS ¿VKHU¶VH[DFWWHVWS  

Figure 5: The number of amino acid differences in the _ helices and ` sheet of HLA-C versus T cell alloreactivity in vitro (HLA-CTLp/106 PBL). The number of pairs in each

(14)

Discussion

,QFRQWUDVWWRWKDWREVHUYHGLQKXPRUDODOORUHDFWLYLW\DJDLQVW0+&FODVV,GLIIHUHQFHVRXU VWXG\ UHYHDOHG WKDW WKH QXPEHU RI DPLQR DFLG VXEVWLWXWLRQV GRHV QRW FRUUHODWH SRVLWLYHO\ ZLWK7FHOOPHGLDWHGDOORUHDFWLYLW\LQYLWUR6SHFL¿FDOO\ZH¿QGWKDWQHLWKHUWKHIUHTXHQF\ RIDPLQRDFLGGLIIHUHQFHVQRUWKHLUSRVLWLRQZLWKLQWKHFODVV,0+&PROHFXOHLVSUHGLFWLYH RIDOORUHDFWLYLW\7KHSRVLWLYHFRUUHODWLRQIRXQGEHWZHHQVXEVWLWXWLRQVRQSRVLWLRQDQG  DQG7 FHOO PHGLDWHG DOORUHDFWLYLW\ LQ SUHYLRXV VWXGLHV FRXOG QRW EH FRQ¿UPHG ,Q

DJUHHPHQW ZLWK RXU SUHYLRXV VWXG\ ZH IRXQG QR UHODWLRQ EHWZHHQ LQKLELWRU\ .,5 OLJDQG PLVPDWFKHVDQG&7/SIUHTXHQF\37KHDEVHQFHRIUHVSRQVHVDJDLQVWDOORJHQHLF3%/ZDVQRW

GXHWRODFNRIVXUIDFH0+&FODVV,H[SUHVVLRQDVWKHVDPSOHVFRXOGEHVHURORJLFDOO\W\SHG IRUWKHPLVPDWFKHG0+&FODVV,DOOHOHV

$FUXFLDOEXWXQH[SHFWHG¿QGLQJLVWKDW+/$&PLVPDWFKHVZLWKPRUHWKDQVXEVWLWXWLRQVLQ the_KHOLFHVDQGPRUHWKDQLQWKH`VKHHWGLGQRWOHDGWR7FHOOPHGLDWHGDOORUHDFWLYLW\LQ

Figure 6: The number of amino acid differences in the _ helices and ` sheet of HLA-A or -B versus T cell alloreactivity in vitro (CTLp/106 PBL). The

number of pairs in each group: 12 within the group with an undetectable CTLp frequency and 23 within the group with detectable CTLp frequency. Please note

that certain pairs have similar numbers of amino acid differences on both _

(15)

YLWURLQDOOFDVHV8QIRUWXQDWHO\WKHJURXSZLWKDQ+/$$RU±%GLIIHUHQFHZDVWRRVPDOODQG LQFOXGHGWRRPDQ\DOOHOHPLVPDWFKHVZLWKIHZDPLQRDFLGGLIIHUHQFHVWREHDEOHWRJHQHUDOL]H WKHVH¿QGLQJVWRDOO0+&FODVV,PLVPDWFKHV7KHDEVHQFHRID7FHOOUHSHUWRLUHDEOHWRUHFRJQL]H H[WHQVLYHO\PLVPDWFKHG0+&FODVV,PROHFXOHVPLJKWOLHLQWKHVHOHFWLRQRI7FHOOVLQWKH WK\PXVDQGSHUKDSVLQWKHSHULSKHU\7KLVZRXOGLPSO\WKDW0+&PROHFXOHVZKLFKKDYH GLYHUJHGVXI¿FLHQWO\IURPWKHVHOHFWLQJDOOHOHPD\EHXQDEOHWRVXSSRUWWKHLQLWLDODVVRFLDWLRQ EHWZHHQWKH7&5DQGLWVGRFNLQJVLWHVRQWKHVHOI0+&FODVV,PROHFXOHVKRZQWREHD¿UVW VWHSLQIRUPLQJDVWDEOHS0+&7&5FRPSOH[227K\PRF\WHVFDSDEOHRIELQGLQJZLWKVXFK DOORJHQHLFS0+&FRPSOH[HVWKHUHIRUHZRXOGEHH[SHFWHGQRWWRSRVVHVVVXI¿FLHQWDI¿QLW\IRU VHOIS0+&IRUSRVLWLYHVHOHFWLRQDQGSHULSKHUDOVXUYLYDO&RQYHUVHO\WKHSRVWVHOHFWLRQ7FHOO UHSHUWRLUHZRXOGEHFRQVWUDLQHGLQLWVUHFRJQLWLRQRIH[WHQVLYHO\PLVPDWFKHG0+&DQGZRXOG QRWIRUPDVWDEOHS0+&7&5FRPSOH[UHVXOWLQJLQWKHDEVHQFHRIDOORUHFRJQLWLRQ )LJXUH 

Figure 7: The possibility for TCR-MHC binding decreases if allogeneic MHC differs too much from autologous MHC. The peptide presented by the MHC

(16)

7KHUHVXOWVUHSRUWHGKHUHVHHPWRFRQWUDGLFWWKHREVHUYDWLRQPDGHE\3HWHUVGRUIDQGFROOHDJXHV WKDWDQDQWLJHQPLVPDWFKOHDGVWRDVWURQJHUDOORJHQHLFLPPXQHUHVSRQVHLQKDHPDWRSRLHWLF VWHPFHOOWUDQVSODQWDWLRQWKDQDQDOOHOHPLVPDWFK23$OOHOHVHQFRGLQJ0+&PROHFXOHVWKDWDUH EHLQJUHFRJQL]HGE\DOORDQWLERGLHVLQGXFHGE\SUHJQDQF\RUEORRGWUDQVIXVLRQVKDYHEHHQ LGHQWL¿HGDV0+&DQWLJHQV%\FRQYHQWLRQLQVWHPFHOOWUDQVSODQWDWLRQRXWFRPHDQDO\VLV WKHWHUP0+&DOOHOHPLVPDWFKUHIHUVWRDGRQRUDQGUHFLSLHQWERWKKDYLQJDGLIIHUHQW0+& DOOHOHRXWRIDIDPLO\RI0+&DOOHOHVWKDWHQFRGHVIRUWKHVDPH0+&DQWLJHQ 23%XWUDWKHU WKDQFRQWUDGLFWLQJWKHLUREVHUYDWLRQRXU¿QGLQJPLJKWH[SODLQZK\DKDHPDWRSRLHWLFVWHP FHOO WUDQVSODQWDWLRQ ZLWK D PDMRU DQWLJHQ PLVPDWFK LQ VRPH FDVHV OHDGV WR D VXFFHVVIXO RXWFRPH

)RUWKLVDQDO\VLVZHXVHG&7/SDVVD\RXWFRPHVIURPGRQRUVHDUFKHVSHUIRUPHGIRUSDWLHQWV EHWZHHQRQWR$OWKRXJKWKH&7/SDVVD\PD\QRWEHWKHPRVWVHQVLWLYHDVVD\ IRU PHDVXULQJ7 FHOODOORUHDFWLYLW\ LWKDV EHHQSURYHQ DFOLQLFDOO\UHOHYDQWSDUDPHWHUIRU WKHDVVHVVPHQWRISUHWUDQVSODQWDQWLSDWLHQW7FHOODOORUHDFWLYLW\LQVWHPFHOOGRQRUV

(17)
(18)

References

   'XTXHVQR\ 5- +/$0DWFKPDNHU D PROHFXODUO\ EDVHG DOJRULWKP IRU KLVWRFRPSDWLELOLW\ GHWHUPLQDWLRQ,'HVFULSWLRQRIWKHDOJRULWKP+XP ,PPXQRO +XP,PPXQRO

   'DQNHUV 0.$ :LWYOLHW 0' 5RHOHQ '/ HW DO 7KH QXPEHU RI DPLQR DFLG VHTXHQFH7KH QXPEHU RI DPLQR DFLG VHTXHQFH GLIIHUHQFHVEHWZHHQSDWLHQWDQGGRQRULVSUHGLFWLYHIRUWKHDQWLERG\UHDFWLYLW\DJDLQVWWKH PLVPDWFKHG+/$DQWLJHQV7UDQVSODQWDWLRQ 7UDQVSODQWDWLRQ

   2XGVKRRUQ0'R[LDGLV,,1YDQGHQ%HUJ/RRQHQ309RRUWHU&(9HUGX\Q:&ODDV )+-)XQFWLRQDO YHUVXV VWUXFWXUDO PDWFKLQJ FDQ WKH &7/S WHVW EH UHSODFHG E\ +/$ DOOHOH)XQFWLRQDOYHUVXVVWUXFWXUDOPDWFKLQJFDQWKH&7/SWHVWEHUHSODFHGE\+/$DOOHOH W\SLQJ"+XP,PPXQRO

   5RHOHQ'/6WREEH,<RXQJ17HWDO3HUPLVVLEOHDQGLPPXQRJHQLF+/$$PLVPDWFKHV F\WRWR[LF 7FHOO SUHFXUVRU IUHTXHQFLHV UHÀHFW JUDIW VXUYLYDO GDWD +XP ,PPXQRO+XP ,PPXQRO 

   'DQNHUV0.$+HHPVNHUN0%$'XTXHVQR\5-HWDO7KH +/$ 0DWFKPDNHU DOJRULWKP7KH+/$0DWFKPDNHUDOJRULWKP LVQRWDVXLWDEOHWRROWRSUHGLFWWKHDOORUHDFWLYHF\WRWR[LF7O\PSKRF\WHUHVSRQVHLQYLWUR 7UDQVSODQWDWLRQ

   <RXQJ175RHOHQ'/:RRG.-:HOVK.,0RUULV3-'DOOPDQ0-3ULPDU\DOORUHDFWLYH F\WRWR[LF7O\PSKRF\WHVDUHQRWFRPPRQO\UHVWULFWHGE\VHOI+/$FODVV,DQWLJHQV+XP ,PPXQRO

   'DYLV 00 %MRUNPDQ 3- 7FHOO DQWLJHQ UHFHSWRU JHQHV DQG 7FHOO UHFRJQLWLRQ 1DWXUH 

   *ROGUDWK$: %HYDQ 0- 6HOHFWLQJ DQG PDLQWDLQLQJ D GLYHUVH7FHOO UHSHUWRLUH 1DWXUH 

   6KHUPDQ/$0RUJDQ'-1XJHQW&7HWDO6HOIWROHUDQFHDQGWKHFRPSRVLWLRQRI7FHOO UHSHUWRLUH,PPXQRO5HV

  =HUUDKQ-+HOG:5DXOHW'+7KH0+&UHDFWLYLW\RIWKH7FHOOUHSHUWRLUHSULRUWRSRVLWLYH DQGQHJDWLYHVHOHFWLRQ&HOO

  $ODP 60 7UDYHUV 3- :XQJ -/ HW DO 7FHOOUHFHSWRU DI¿QLW\ DQG WK\PRF\WH SRVLWLYH VHOHFWLRQ1DWXUH

  5XGROSK0*:LOVRQ,$7KHVSHFL¿FLW\RI7&5S0+&LQWHUDFWLRQ&XUU2SLQ,PPXQRO 

  0DGGHQ '5 *RUJD -& 6WURPLQJHU -/ :LOH\ '& 7KH WKUHHGLPHQVLRQDO VWUXFWXUH RI +/$%DWcUHVROXWLRQVXJJHVWVDJHQHUDOPHFKDQLVPIRUWLJKWSHSWLGHELQGLQJWR 0+&&HOO

  &KLHQ<+ 'DYLV 00 +RZ DOSKD EHWD7FHOO UHFHSWRUV µVHH¶ SHSWLGH0+& FRPSOH[HV ,PPXQRO7RGD\

  KWWSZZZHELDFXNLPJWKOD

(19)

  0RUHWWD $ 9LWDOH 0 %RWWLQR & HW DO 3 PROHFXOHV DV SXWDWLYH UHFHSWRUV IRU PDMRU KLVWRFRPSDWLELOLW\ FRPSOH[ 0+&  FODVV , PROHFXOHV LQ KXPDQ QDWXUDO NLOOHU 1.  FHOOV$QWLSDQWLERGLHVUHFRQVWLWXWHO\VLVRI0+&FODVV,SURWHFWHGFHOOVLQ1.FORQHV GLVSOD\LQJGLIIHUHQWVSHFL¿FLWLHV- ([S 0HG -([S0HG   &RORQQD0%RUVHOOLQR*)DOFR0)HUUDUD*%6WURPLQJHU-/+/$&LVWKHLQKLELWRU\ OLJDQGWKDWGHWHUPLQHVGRPLQDQWUHVLVWDQFHWRO\VLVE\1.DQG1.VSHFL¿FQDWXUDONLOOHU FHOOV3URF1DWO$FDG6FL86$   0DQGHOERLP25H\EXUQ+79DOHV*RPH]0HWDO3URWHFWLRQIURPO\VLVE\QDWXUDONLOOHU FHOOVRIJURXSDQGVSHFL¿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

  3HWHUVGRUI (: +DQVHQ -$ 0DUWLQ 3- HW DO 0DMRUKLVWRFRPSDWLELOLW\FRPSOH[ FODVV ,0DMRUKLVWRFRPSDWLELOLW\FRPSOH[ FODVV , DOOHOHVDQGDQWLJHQVLQKHPDWRSRLHWLFFHOOWUDQVSODQWDWLRQ1 (QJO - 0HG 1(QJO-0HG 

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¿FWRSDWLHQW+/$FODVV,DQWLJHQVFRUUHODWLQJZLWKPRUWDOLW\DIWHUXQUHODWHG%07%U -+DHPDWRO   .HHYHU7D\ORU&$3DVVZHJ-.DZDQLVKL<&DVSHU-)ORPHQEHUJ1%D[WHU/RZH/$ $VVRFLDWLRQ RI GRQRUGHULYHG KRVWUHDFWLYH F\WRO\WLF DQG KHOSHU 7 FHOOV ZLWK RXWFRPH IROORZLQJ DOWHUQDWLYH GRQRU7 FHOOGHSOHWHG ERQH PDUURZ WUDQVSODQWDWLRQ %RQH 0DUURZ 7UDQVSODQW

(20)

  'ROH]DORYD/9UDQD0'REURYROQD0HWDO&\WRWR[LF 7 O\PSKRF\WH SUHFXUVRU IUHTXHQF\&\WRWR[LF7O\PSKRF\WHSUHFXUVRUIUHTXHQF\ DQDO\VLV LQ WKH VHOHFWLRQ RI +/$ PDWFKHG XQUHODWHG GRQRUV IRU KHPDWRSRLHWLF VWHP FHOO WUDQVSODQWDWLRQ WKH FRUUHODWLRQ RI &7/S IUHTXHQF\ ZLWK +/$ FODVV , JHQRW\SLQJ DQG D*9+'GHYHORSPHQW1HRSODVPD

(21)

Referenties

GERELATEERDE DOCUMENTEN

The analyses con firmed the same systematic and stepwise effects of donor type on the cumulative excess event rates in overall survival, non-relapse mortality and relapse-free

+/$0DWFKPDNHU FRQVLGHUV RQO\ WULSOHWV LQ DQWLERG\ DFFHVVLEOH SRVLWLRQV RI WKH +/$ PROHFXOH ZKLFK LV SUREDEO\ WKH PDLQ UHDVRQ WKDW WKH FRUUHODWLRQ ZLWK

The relation between the SSM score of donor/patient couples with a single HLA-A or -B allele mismatch and T cell alloreactivity in vitro (CTLp/10 6 PBL).. The number of pairs in

Transplanting a single MHC class I mismatched graft from a female donor to a male recipient had significant adverse effect on transplantation outcome independent

127 VHDUFKWLPHVSDQ WREHVXEPLWWHG 7KHPHGLDQWLPHQHHGHGWR¿QGDGRQRUIRUSDWLHQWV RI 1RUWKZHVW (XURSHDQ RULJLQ GHFUHDVHG IURP  PRQWKV WR  PRQWKV DQG

JURRW DDQWDO EORHGNDQNHUV ]RDOV OHXNHPLH HQ EORHGVWRRUQLVVHQ ]RDOV HUQVWLJH YRUPHQ YDQ DDQJHERUHQ EORHGDUPRHGH RI HHQ VOHFKW IXQFWLRQHUHQG DIZHHUV\VWHHP

0DUWLQ%DUWKRORPHXV$OH[DQGHU+HHPVNHUNZHUGJHERUHQRSMXQLWH+DDUOHP$DQ KHW 0HQGHO &amp;ROOHJH WH +DDUOHP EHKDDOGH KLM LQ  ]LMQ +$92 GLSORPD HQ LQ

Allogeneic haematopoietic stem cell donation and transplantation across the MHC class I barrier: &#34;Faster is better than more.. More is better